Korean Circ J.  1996 Dec;26(6):1091-1098. 10.4070/kcj.1996.26.6.1091.

Effect of Percutaneous Transluminal Coronary Angioplasty in Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction

Abstract

BACKGROUND
Cardiogenic shock is the most common cause of in-hospital mortality after acute myocardial infarction. Despite improvement in coronary care, the in-hospital mortality rate of cardiogenic shock is very high in conventional conservative therapy. Recently, it was suggested that coronary angioplasty may reduce the mortality associated with cardiogenic shock. METHOD: Thirteen consecutive patients with cardiogenic shock who underwent coronary angioplasty were studied. Shock was not induced by mechanical complications, arrhythmia, hypovolemia and other reversible cause. We collected and analyzed the clinical, hemodynamic survivor groups.
RESULTS
Of 13 patients, 11 had successful reperfusion of the infarct-related coronary artery and 2 had unsuccessful reperfusion. Of 11 patients with successful angioplasty, 8 survived at the time of hospital discharge. All patents with unsuccessful angioplasty died in the hospital. Therefore overall hospital survival rate was 62% and the rate increased to 73% in patients with successful reperfusion. Survivor and non-survivor groups in clinical, hemodynamic and angiographic variables were similar except systolic blood pressure and the presence of successful reperfusion.
CONCLUSION
In patients with cardiogenic shock, the patency of infarct-related coronary artery was strongly associated with in-hospital mortality. This findings support aggressive interventional strategy in patient with cardiogenic shock complicating acute myocardial infarction.

Keyword

Cardiogenic shock; Percutaneous transluminal coronary angioplasty

MeSH Terms

Angioplasty
Angioplasty, Balloon, Coronary*
Arrhythmias, Cardiac
Blood Pressure
Coronary Vessels
Hemodynamics
Hospital Mortality
Humans
Hypovolemia
Mortality
Myocardial Infarction*
Reperfusion
Shock
Shock, Cardiogenic*
Survival Rate
Survivors
Full Text Links
  • KCJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr